Device Trial Radar · NCT04089059
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
Last checked: Nov 19, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
738
Actual
Start
Jan 10, 2020
Primary completion
Apr 2028
Study completion Apr 2028
Sponsor
- Lead sponsor
- Endotronix, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 13, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).
Conditions
- Heart Failure NYHA Class III
Interventions
Cordella™ Pulmonary Artery Sensor SystemDevice
The Cordella PA Sensor System (CorPASS) is intended to measure, record, and transmit pulmonary artery pressure (PAP) data from NYHA Class III heart failure patients at home to clinicians for assessment and patient-centered heart failure management and comprises of seven subsystems that operate together to take daily Pulmonary Artery Pressure (PAP) readings at a patient's home and transmit the results to a care provider for evaluation. 1. Cordella Sensor 2. Cordella Delivery System 3. myCordella Patient Reader 4. Reader Dock 5. Cordella Calibration Equipment (CalEQ) 6. myCordella Hub 7. Cordella Data Analysis Platform (CDAP)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy 6 Month Incidence of HF Related Hospitalizations (HFH) or All-cause MortalityTime frame: 6 months
- Safety: Freedom From Device/System Related ComplicationTime frame: 6 months
- Safety: Freedom From Pressure Sensor FailureTime frame: 6 months
Locations
74 sites in 3 countries. Site status is shown where the registry gives one.
Ascension St Vincent's
Birmingham, Alabama
Huntsville Hospital
Huntsville, Alabama
Phoenix Cardiovascular Research Group/Insight
Phoenix, Arizona
71 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.